Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cholesterol drug
Pharma
Esperion to go private in potential $1.1B buyout by ArchiMed
After a March M&A move of its own, Esperion Therapeutics is itself being acquired and taken private by healthcare investment firm ArchiMed.
Fraiser Kansteiner
May 1, 2026 11:26am
FDA untitled letter skewers Esperion's Nexlizet TV ad
Jan 7, 2026 12:00pm
FDA endorses LIB's convenient cholesterol-lowering PCSK9 drug
Dec 15, 2025 11:33am
Fierce Biotech
Merck's PCSK9 drug mounts injectable-like cholesterol reductions
Nov 10, 2025 10:59am
Orient Pharma, AvKARE recall some 80K bottles of cholesterol med
Jul 23, 2025 8:32am
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
May 15, 2025 3:52pm
